Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mammography Use in the United States Decreases

By HospiMedica International staff writers
Posted on 24 Feb 2009
Nearly two thirds of the states in the United States saw a small decrease in mammography utilization between the years 2000 and 2006, according to new data.

According to researchers from the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), new data showed that although mammography use in 17 states including Minnesota, Tennessee, Georgia, and Alabama had increased slightly between 2002 and 2006, mammography use in 34 states and the District of Columbia including Utah, South Carolina, New Mexico, and Delaware had a slight decrease. More...
The decrease in utilization ranged from -0.3% to -5.3%. The CDC also reviewed incidence rates and found that between 2000 and 2004 all but one state (Tennessee) had a decrease in breast cancer incidence rates. There was no clear pattern among the states, however, in regards to region, average age, average income, or population density.

"The Government Accountability Office reported that there was a 6% decrease in mammography facilities use across the US, but despite their report there is a growing concern that this rate in low resource areas could be higher,” said Jacqueline Miller, M.D., lead author of the study. "Women in these areas may not have a convenient place to go. Also, reports have shown that insurance co-pays were related to women not getting their mammogram and we know that some insurance companies have increased their co-pay requirements. When there are more out of pocket costs, women start weighing the costs of screening against other competing factors,” said Dr. Miller.

According to Dr. Miller, tracking breast cancer screening practices and breast cancer incidence trends at the state-level may enable clinicians to detect changes early. If the screening rates are seen to be going down, clinicians can work to identify where and who interventions need to be targeted, thus helping to decrease invasive breast cancer incidences and breast cancer mortalities.

"We need to do more to get the word out to women and healthcare providers about the importance of mammography. At the state-level, we hope to get the word out in different avenues to reach different audiences,” concluded Dr. Miller.

The study was published in the February 2007 issue of the American Journal of Roentgenology (AJR).

Related Links:

Centers for Disease Control and Prevention





Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.